Form D — ADIAL PHARMACEUTICALS, INC.
0001213900-25-042848 · filed 2025-05-14
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $4,815,379
- Total sold
- $4,815,379
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ADIAL PHARMACEUTICALS, INC.
- CIK
- 1513525
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4870 SADLER ROAD
GLEN ALLEN, VA 23060 - Phone
- (804) 487-8196
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Cary J. Claiborne · Executive OfficerGlen Allen, VA Find on LinkedIn ↗
-
Vinay Shah · Executive OfficerGlen Allen, VA Find on LinkedIn ↗
-
James K. Anderson · DirectorGlen Allen, VA Find on LinkedIn ↗
-
Robertson H. Gilliland · DirectorGlen Allen, VA Find on LinkedIn ↗
-
James W. Newman, Jr. · DirectorGlen Allen, VA Find on LinkedIn ↗
-
Kevin W. Schuyler, CFA · DirectorGlen Allen, VA Find on LinkedIn ↗
-
Tony Goodman · Executive OfficerGlen Allen, VA Find on LinkedIn ↗
View original on SEC EDGAR.